Indeed, ubiquitin-mediated degradation of CCND3 by FBXL2 has been demonstrated in lung cancer, while in breast cancer cells, the RNA-binding protein IMP-3 can regulate CCND3 protein expression by directly binding to its mRNAs [62,63]. This evidence concerns the gene FBXL2 and lung carcinoma.